205 related articles for article (PubMed ID: 27595456)
1. Gastrointestinal bleeding from vascular malformations: Is octreotide effective to rescue difficult-to-treat patients?
Iannone A; Principi M; Barone M; Losurdo G; Ierardi E; Di Leo A
Clin Res Hepatol Gastroenterol; 2016 Sep; 40(4):373-7. PubMed ID: 27595456
[TBL] [Abstract][Full Text] [Related]
2. Long-time octreotide in an adolescent with severe haemorrhagic gastrointestinal vascular malformation.
Classen CF; Haffner D; Hauenstein C; Wolf R; Kyank U
BMJ Case Rep; 2011 Aug; 2011():. PubMed ID: 22688939
[TBL] [Abstract][Full Text] [Related]
3. Octreotide long-active release in the treatment of gastrointestinal bleeding due to vascular malformations: Cost-effectiveness study.
Klímová K; Padilla-Suárez C; Giménez-Manzorro Á; Pajares-Díaz JA; Clemente-Ricote G; Hernando-Alonso A
Rev Esp Enferm Dig; 2015 Feb; 107(2):79-88. PubMed ID: 25659389
[TBL] [Abstract][Full Text] [Related]
4. The efficacy of octreotide therapy in chronic bleeding due to vascular abnormalities of the gastrointestinal tract.
Nardone G; Rocco A; Balzano T; Budillon G
Aliment Pharmacol Ther; 1999 Nov; 13(11):1429-36. PubMed ID: 10571598
[TBL] [Abstract][Full Text] [Related]
5. [Octreotide in the treatment of acute gastrointestinal hemorrhage caused by ruptured esophageal varices].
Arfaoui D; Elloumi H; Ajmi S
Tunis Med; 2004 Oct; 82(10):947-50. PubMed ID: 15686191
[TBL] [Abstract][Full Text] [Related]
6. Somatostatin or octreotide in acute variceal bleeding.
Hadengue A
Digestion; 1999; 60 Suppl 2():31-41. PubMed ID: 10207229
[TBL] [Abstract][Full Text] [Related]
7. Long acting release-octreotide as "rescue" therapy to control angiodysplasia bleeding: A retrospective study of 98 cases.
Nardone G; Compare D; Scarpignato C; Rocco A
Dig Liver Dis; 2014 Aug; 46(8):688-94. PubMed ID: 24893688
[TBL] [Abstract][Full Text] [Related]
8. Long-term efficacy of octreotide in the prevention of recurrent bleeding from gastrointestinal angiodysplasia.
Junquera F; Saperas E; Videla S; Feu F; Vilaseca J; Armengol JR; Bordas JM; Piqué JM; Malagelada JR
Am J Gastroenterol; 2007 Feb; 102(2):254-60. PubMed ID: 17311647
[TBL] [Abstract][Full Text] [Related]
9. Somatostatin for acute severe bleeding from portal hypertensive gastropathy.
Kouroumalis EA; Koutroubakis IE; Manousos ON
Eur J Gastroenterol Hepatol; 1998 Jun; 10(6):509-12. PubMed ID: 9855068
[TBL] [Abstract][Full Text] [Related]
10. Octreotide in the management of recurrent gastrointestinal bleed in patients supported by continuous flow left ventricular assist devices.
Loyaga-Rendon RY; Hashim T; Tallaj JA; Acharya D; Holman W; Kirklin J; Pamboukian SV
ASAIO J; 2015; 61(1):107-9. PubMed ID: 25232774
[TBL] [Abstract][Full Text] [Related]
11. Octreotide for left ventricular assist device-related gastrointestinal hemorrhage: can we stop the bleeding?
Rennyson SL; Shah KB; Tang DG; Kasirajan V; Pedram S; Cahoon W; Malhotra R
ASAIO J; 2013; 59(4):450-1. PubMed ID: 23820288
[TBL] [Abstract][Full Text] [Related]
12. Effects of a somatostatin analogue in occult gastrointestinal bleeding: a case report.
Tamagno G; Mioni R; De Carlo E; Maffei P; Rubello D; Sicolo N
Dig Liver Dis; 2004 Dec; 36(12):843-6. PubMed ID: 15646433
[TBL] [Abstract][Full Text] [Related]
13. Octreotide for recurrent intestinal bleeding due to ventricular assist device.
Coutance G; Saplacan V; Belin A; Repessé Y; Buklas D; Massetti M
Asian Cardiovasc Thorac Ann; 2014 Mar; 22(3):350-2. PubMed ID: 24585917
[TBL] [Abstract][Full Text] [Related]
14. [Octreotide in bleeding caused by intestinal angiodysplasia].
Lourdes Ruiz Rebollo M; Barrio Andrés J; Fernández-Orcajo P; Prada Lobato J; Mena Martín FJ; Velicia Llames R; Caro-Paton A
Gastroenterol Hepatol; 2008 Dec; 31(10):713-4. PubMed ID: 19174089
[No Abstract] [Full Text] [Related]
15. Terlipressin vs. octreotide in bleeding esophageal varices as an adjuvant therapy with endoscopic band ligation: a randomized double-blind placebo-controlled trial.
Abid S; Jafri W; Hamid S; Salih M; Azam Z; Mumtaz K; Shah HA; Abbas Z
Am J Gastroenterol; 2009 Mar; 104(3):617-23. PubMed ID: 19223890
[TBL] [Abstract][Full Text] [Related]
16. Safety and efficacy of octreotide in the immediate control of oesophageal variceal bleeding.
McKiernan PJ
J Pediatr Gastroenterol Nutr; 2004 Oct; 39(4):437-8; author reply 438. PubMed ID: 15448442
[No Abstract] [Full Text] [Related]
17. [Therapeutic effect of somatostatin analog octreotide on esophaged-gastric varices bleeding].
Zhang AG; Wang JB; Zhao P; Jiao J; Wang G
Zhonghua Gan Zang Bing Za Zhi; 2003 Mar; 11(3):152. PubMed ID: 12681061
[No Abstract] [Full Text] [Related]
18. [Vascular gastric anomalies as a cause of relapsing bleeding].
Golubović G; Kiurski M; Spica V; Tomasević R; Pavlović A; Dukić N
Vojnosanit Pregl; 2008 Sep; 65(9):710-3. PubMed ID: 18814510
[TBL] [Abstract][Full Text] [Related]
19. Long-acting octreotide is effective in controlling rebleeding angiodysplasia of the gastrointestinal tract.
Orsi P; Guatti-Zuliani C; Okolicsanyi L
Dig Liver Dis; 2001 May; 33(4):330-4. PubMed ID: 11432511
[TBL] [Abstract][Full Text] [Related]
20. Multicentre, open-label, randomised, parallel-group, superiority study to compare the efficacy of octreotide therapy 40 mg monthly versus standard of care in patients with refractory anaemia due to gastrointestinal bleeding from small bowel angiodysplasias: a protocol of the OCEAN trial.
Grooteman KV; van Geenen EJ; Drenth JP
BMJ Open; 2016 Sep; 6(9):e011442. PubMed ID: 27619827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
